ABSTRACT. The objective of this study was to evaluate the effect of Moquiniastrum polymorphum ssp floccosum ethanolic extract (MPEE) on 1,2 dimethylhydrazine (DMH)-induced colorectal carcinogenesis in mice. Forty-two male Swiss mice (Mus musculus) were subdivided into six groups (N = 7/group): negative control, DMH, MPEE, pre-treatment, simultaneous, and post-treatment. Results showed that MPEE has antigenotoxic potential on the tested protocols pre-and silmultaneous treatment, and the percent damage reductions (%DRs) were 81.88 and 93.12%, respectively. The micronucleus test demonstrated that MPEE has great antimutagenic activity, with %DRs higher than 77.09 in the associated groups. The aberrant crypt focus assay demonstrated anticarcinogenic potential of MPEE as the associated groups showed %DRs that ranged from 62.13 to 95.14%. The study shows that MPEE is nontoxic and has chemopreventive and anticarcinogenic activity, thus it may prove to be a promising medicinal plant in view of its demonstrated properties.
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INTRODUCTION
According to the World Health Organization (WHO, 2016), 14 million people are currently estimated to have cancer in the world, and 8.2 million people die annually as a result of the disease.
The literature data show the relationship between cancer and inflammation (Diniz et al., 2012; Hu et al., 2015) . Among the inflammation-induced cancers, the colorectal cancer ranks third among the most common malignant neoplastic diseases and comes fourth in cancerrelated mortality (Labianca et al., 2013) . This type of neoplasia is prevalent in industrialized and Western countries, and is growing in Asian countries, where historically the risk of the disease was low (West et al., 2012; ACS, 2016) .
The Brazilian National Cancer Institute (Instituto Nacional do Câncer -INCA, 2016) estimated 34,280 new cases of colorectal cancer to occur in Brazil in 2016. These data demonstrate the high prevalence of the disease, which foster studies correlating the country's biodiversity of plants with ethnobotanical knowledge in search of new anticancer compounds.
Moquiniastrum polymorphum, previously identified as Gochnatia polymorpha and popularly called cambará, belongs to the Asteraceae family (David et al., 2014) . Studies show that the plant is rich in sesquiterpene lactones, sesquiterpenes, diterpenes, triterpenes, flavonoids, coumarins, phenolic compounds, and essential oils (Strapasson et al., 2012) .
The cambará leaves, flowers and barks are widely used in the popular medicine as an infusion, especially for the treatment of respiratory tract inflammation, and infections (Bueno et al., 2005; Arambarri et al., 2008; Pionerdo et al., 2011) . The anti-inflammatory activity of cambará ethanolic extract stem has also been reported in Swiss mice, as well as the 11,13-dihydrozaluzanin C isolated compound (Pionerdo et al., 2011) . Later on, tests with female Swiss mice also demonstrated that the extract is neither mutagenic nor teratogenic. This finding was possible by means of the micronucleus assay and because no embryotoxicity was observed in experiments with pregnant mice.
The effective anti-inflammatory activity was also demonstrated by the paw edema test induced by Freund's complete adjuvant (CFA) (David et al., 2014) . Finally, our research group described the antineoplastic activity of this extract, its fractions, and isolated compounds in both in vitro and in vivo assays (Strapasson et al., 2012; Martins et al., 2015) . The in vivo assays revealed that the dichloromethane fraction of this medicinal plant reduces the growth of Walker 256 carcinosarcoma (Martins et al., 2015) .
Given the above, the present study evaluated the effects of the M. polymorphum ethanolic extract (MPEE) stem for the action on the genetic integrity and splenic phagocytosis, and its ability to inhibit the formation of aberrant crypt foci in the intestinal mucosa of Swiss mice.
MATERIAL AND METHODS

Collection and identification of botanical material
The trunk barks of M. polymorphum ssp floccosum, naturally occurring in Curitiba, PR, were collected in May 2011. The plant was identified by Prof. Dr. Armando Carlos Cervi (Department of Botany -UFPR). A botanical voucher was deposited in the herbarium of the same institution under No. 30100.
Preparation of the MPEE
The barks were dried at 40°C, milled and extracted three times with 95% ethanol (500 mL per 100 g of material) at room temperature, with solvent changed every 24 h. The solutions were combined and the solvent evaporated under reduced pressure, providing the crude extract in a 3% yield in relation to the dry initial weight.
The M. polymorphum ssp floccosum was diluted in a hydroalcoholic solution with 1.2% ethanol 95°GL at a concentration of 100 mg/kg body weight (b.w.), and administered by oral gavage. This dose was chosen for having effective anti-inflammatory activity; higher doses do not indicate benefits for use (Piornedo et al., 2011; David et al., 2014) .
Chemicals
The DNA damage-inducing and cancer-promoting agent 1,2-dimethylhydrazine (DMH, ; Sigma-Aldrich, St. Louis, MO, USA) was diluted in a 0.37 mg/ mL ethylenediaminetetraacetic acid (EDTA) solution and administered intraperitoneally (ip) to animals following a modified version of the protocol of Rodrigues et al. (2002) . DMH was administered in 4 doses of 35 mg/kg b.w. twice weekly for 2 weeks. Four applications of DMH, twice weekly for 2 weeks, were used to induce aberrant crypt foci .
Animals
A total of 42 male Swiss mice (Mus musculus) in reproductive age were used. The animals were obtained from the Central Vivarium of the Center for Biological and Health Sciences, Federal University of Mato Grosso do Sul (Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul -CCBS/UFMS) and the experiment was conducted in the Biocapri Laboratory vivarium (CCBS/UFMS).
The animals were housed in propylene boxes covered with wood shavings and were fed commercial feed (Nuvital ® ) and filtered water ad libitum. The animals were maintained at controlled temperature (22° ± 2°C) and humidity (55 ± 10%) on a ventilated cage rack (Alesco ® e520) with a photoperiod of 12-h light/12-h dark.
The experiment was conducted according to the guidelines of the Brazilian College of Animal Experimentation, and approved by the Federal University of Mato Grosso do Sul Ethics Committee on Animal Use (Protocol No. 401/2012) .
Experimental design
The animals were divided into six groups (N = 7/group): negative control, DMH, MPEE, pre-treatment, simultaneous, and post-treatment. The experimental period comprised 12 weeks. The animals of the negative control group were treated with hydroalcoholic solution orally (po) every day until the twelfth week; in the third and fourth weeks two doses of EDTA solution (ip) were administered.
The animals of the DMH group (positive control group) received hydroalcoholic solution (po) until the twelfth week; in the third and fourth weeks of experimentation two doses of DMH solution (ip) were administrated concomitantly with hydroalcoholic solution (po).
The animals of the MPEE group received MPEE solution (po) daily until the twelfth week; and two doses of EDTA (ip) were administered in the third and fourth weeks, concurrently with MPEE.
In the pre-treatment group, the animals were treated with MPEE (po) for the first 2 weeks (first and second); in the subsequent 2 weeks (third and fourth), DMH was administered (ip) concurrently with the hydroalcoholic solution orally. In the following weeks, only hydroalcoholic solution (po) was administered until the last day of experimentation.
Regarding the simultaneous group, the animals were treated with hydroalcoholic solution (po) for the first 2 weeks (first and second); for the subsequent 2 weeks (third and fourth), MPEE (po) was administered daily, and DMH (ip) twice weekly. From the fifth to twelfth week, the animals resumed receiving hydroalcoholic solution (po).
In the post-treatment group, hydroalcoholic solution was administered (po) daily in the first 4 weeks. In the third and fourth weeks, DMH (ip) was administered twice weekly, and in the next eight weeks (fifth to twelfth), only MPEE was administered (po).
Peripheral blood samples were collected to evaluate the genetic integrity. The collections (via caudal venipuncture) occurred 24 and 48 hafter the last administration of EDTA or DMH, for the comet and micronucleus assays, respectively. The collection of spleen and intestines for evaluating splenic phagocytosis and aberrant crypt foci, respectively, was performed at the end of the 12th week of experimentation.
For the analysis of biometric parameters, the body weight was assessed at the beginning and end of experiment. At the end, the body weight and the organs (heart, lung, kidney, liver, and spleen) were evaluated.
Biological assays
Comet assay
Comet assays were performed according to the procedure described by Oliveira et al. (2013) as follows. Peripheral blood (20 µL) was collected (24 h after the last dose of EDTA or DMH) into heparinized cryotubes, homogenized with 120 µL 1.5% low-melting-point agarose at 37°C, and placed onto slides coated with standard 5% agarose. The slides were covered with glass coverslips and cooled to 4°C for 20 min. After coverslip removal, the slides from all experiments were immersed in freshly prepared lysis solution composed of 89 mL stock lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM Tris adjusted to pH 10 with solid NaOH, 890 mL distilled water, and 1% sodium lauroyl sarcosinate), 1 mL Triton X-100 (Merck, Germany), and 10 mL dimethyl sulfoxide. The samples were lysed for 1 h at 4°C with protection from light. The slides were then transferred to an electrophoresis tank containing buffer with a pH of >13 (300 mM NaOH and 1 mM EDTA prepared from a stock solution of 200 mM EDTA and 10 N NaOH, pH 10.0) at 4°C and incubated for 20 min for DNA denaturation. Electrophoresis was performed at 300 mA and 25 V (1.25 V/cm) for 20 min. Subsequently, the slides were neutralized with buffer (0.4 M Tris-HCl, pH 7.5) in 3 cycles of 5 min each, airdried, fixed in absolute ethanol for 10 min, and stored for later analysis. Next, 100 µL ethidium bromide (20 mg/mL) was used for staining. The samples were evaluated at 40X magnification under a fluorescence microscope (Bioval ® Model G 2000A, Brazil) fitted with a 420-to 490-nm excitation filter and a 520-nm barrier filter. In total, 100 cells per animal were visually analyzed, and the comets were classified as follows: class 0, undamaged cells without tails; class 1, cells with tails smaller than the nucleoid diameter; class 2, cells with tails 1-to 2-fold the nucleoid diameter; and class 3, cells with tails greater than 2-fold the nucleoid diameter. According to the protocol, apoptotic cells and those with totally fragmented nucleoids were not counted. The total score was calculated by adding the results from the multiplication of the total number of observed cells per injury class by the class value. Statistical analysis was performed with analysis of variance (ANOVA) and the Tukey test (P < 0.05).
Micronucleus assay
The micronucleus assay development method described by Oliveira et al. (2009) was used. Slides were coated with 20 µL acridine orange (1 mg/mL). Next, 20 µL peripheral blood was deposited onto each slide, covered with a coverslip, and stored in a freezer (-20°C) for a minimum of 7 days. Analysis was performed at 40X magnification under an epifluorescence microscope (Bioval ® , Model L 2000A, Brazil) with a 420-to 490-nm excitation filter and a 520-nm barrier filter. A total of 2000 cells/animal were analyzed, and statistical analysis was performed with ANOVA and the Tukey test (P < 0.05).
Phagocytosis assay
Phagocytosis assays were performed according to the procedure described by Schneider et al. (2016) . In the twelfth week, after euthanasia, the spleens were collected, and 1/3 of the organ was macerated in saline to obtain a homogenous cell suspension by repeated aspiration with a Pasteur pipette. Then, 100 µL of this cell suspension was deposited onto a slide previously coated with acridine orange (1 mg/mL) covered with a glass coverslip. The slides were stored in a freezer until the time of analysis, performed with a fluorescence microscope (Bioval ® , Model L 2000A) at 40X magnification, fitted with a 420-490-nm filter and a 520-nm barrier filter. A total of 200 cells/animal were analyzed.
Percentage points were used to calculate the extent of phagocytosis reduction/ increase. For this purpose, the frequency of cells that exhibited evidence of phagocytosis in the negative control group was considered 100%, and the percentage for each associated group was calculated by the rule of three. This calculated value was then subtracted from 100, and the result is presented as the reduction/increase in phagocytic activity in percentage points.
Aberrant crypt focus assay
The collected mouse colons and rectums were washed in a physiological buffer solution and then dissected for subsequent fixation in 10% buffered formalin for a minimum of 24 h. For analysis, each colorectal segment was stained with 10% methylene blue solution for 10 min and placed on a slide mucosal side up. Analysis was performed at 10X magnification using a light microscope. The entire mucosa was evaluated to identify and quantify aberrant crypt foci. Aberrant crypt foci were identified using the criteria described by Mauro et al. (2013) as follows. I) In foci with a single crypt, the aberrant crypt is coated in a thick epithelial layer with an elliptical luminal opening at least 2-fold larger than those of the surrounding normal crypts. II) In foci with 2 or more crypts, the aberrant crypts form distinct blocks and occupy an area larger than that occupied by an equal number of crypts of normal morphology. In the latter, no normal crypts separate the aberrant crypts in the foci. Comparison of the aberrant crypt focus test data (total number of foci of aberrant crypts, number of aberrant crypts per foci, and crypt/focus ratio) from the experimental groups was performed with ANOVA and the Tukey test (P < 0.05).
Calculation of percent damage reduction (%DR)
The percentage of DMH damage reduction by MPEE was calculated as suggested by Manoharan and Banerjee (1985) : 
Statistical analysis
The results are reported as means ± standard deviation or as percentages. The data were analyzed using ANOVA or the Tukey test (GraphPad Prism, V. 3.02; Graph-Pad Software Inc., San Diego, CA, USA). The significance level was set at P < 0.05 or P > 0.05.
RESULTS
Biometrical parameters
The animal's initial and final weights and weight gain were not significantly different (P > 0.05) ( Table 1 ). The same occurred with the absolute weight of the hearts, lungs, kidneys, and spleens, and with the relative weight of the hearts, lungs, livers, and spleens (Table 2) . On assessing the absolute weight of the livers, a reduction (P < 0.05) was observed in MPEE, simultaneous, and post-treatment groups. It was also found increased (P < 0.05) relative weight of the kidneys in the post-treatment group, when compared with the others (Table 3) . Only the liver absolute weight changed significantly.
This difference was not seen in the relative weight, which suggests the absence of toxicity. Nevertheless the relative weight of the kidneys in the post-treatment protocol presented a statistically significant increase, and this fact needs to be better evaluated in future trials on kidney function.
Genetic integrity and DNA damage prevention
The comet and micronucleus assays showed that MPEE has no genotoxic or mutagenic activity since the frequency of damaged and/or micronucleated cells, respectively, did not differ from control (Tables 4 and 5) .
Antigenotoxic activity was observed in the pre-treatment and simultaneous treatment protocols and the %DRs were 81.88 and 93.12, respectively (Table 4 ). All protocols showed antimutagenic activity and the %DRs were 77.09, 94.41, and 78.21 for the pre-treatment, simultaneous treatment, and post-treatment groups, respectively (Table 5) . The differences between means are not statistically significant (ANOVA/Tukey test; P > 0.05). 
Splenic phagocytosis
Regarding splenic phagocytosis activity, the DMH, MPEE, and pre-treatment groups presented reduction of cells that exhibited evidence of phagocytosis of 3.80, 28.37, and 30.45 percentage points, respectively. On the other hand, in the simultaneous and post-treatment groups, an increase in the percentage points of cells that exhibited evidence of phagocytosis ranging from 39.10 to 94.82% was observed ( Table 5 . Total frequency and means ± standard error of the micronucleus frequency.
%DR: percent damage reduction; SE: standard error. Different letters indicate statistically significant differences (ANOVA/Tukey test; P < 0.05). Reduction in the formation of aberrant crypt foci MPEE did not cause the formation of aberrant crypt focus, rather it avoided the formation of this tumor biomarker. The %DRs were 62.13, 86.40, and 95.14 for the pretreatment, simultaneous treatment, and post-treatment protocols, respectively (Table 7) . 
DISCUSSION
The toxicological (Vasconcelos et al., 2007) and toxicogenetic (David et al., 2014) evaluations are important as the indiscriminate use of herbs and medicinal plants constitutes a public health issue. In addition, the control of commercialization exerted by official agencies and the studies to guarantee the safe use of plants are incipient regarding medicinal plants.
M. polymorphum is a plant often used in popular medicine for the treatment of inflammations (Bueno et al., 2005; Arambarri et al., 2008) . Two studies were found about its effects on DNA, one with salmonella (Horn and Vargas, 2008) and another with female pregnant mice (David et al, 2014) . The latter indicates that MPEE is neither mutagenic nor teratogenic, which suggests that the use of this medicinal plant is safe even during pregnancy. Our findingsconfirm the compound safety and innovatively show that MPEE is neither genotoxic nor mutagenic in male mice even when administered for 8 consecutive weeks, a period longer than other protocols described for this plant.
The antiproliferative and cytotoxic effects of M. polymorphum have been described on U251 tumor lineage (glioma), UACC-62 (melanoma), MCF-7 (breast cancer), NCI-ADR/ RES (drug-resistant ovarian cancer), 786.0 (kidney), NCI-H460 (lung), PC-3 (prostate), OVCAR-3 (ovary), , and K562 (leukemia) (Strapasson et al., 2012) . Martins et al. (2015) also demonstrated a reduced growth of the Walker 256 tumor. The present study is the first to describe the chemopreventive effects of this plant and its ability to prevent chemical carcinogenesis in the intestine.
According to Steward and Brown (2013) , chemoprevention is the ability that natural or synthetic products have to avoid cancer and/or suppress or reverse carcinogenesis in its early stages. Therefore, short-term tests, such as comet and micronucleus assays, are successfully employed to screen for anti-cancer substances. By means of these tests, the present study demonstrated the efficiency of MPEE in avoiding genotoxic and mutagenic damage, thus confirming the chemopreventive effect of the extract (94.41% damage reduction). This result pointed to the need for a sequential test with medium or long-term studies that would evaluate tumor biomarkers or even installed neoplasia (Maurin et al., 2007) . Given the above, we have chosen a medium-term test, the aberrant crypt focus assay (Bazo et al., 2002; Agner et al., 2005) .
The multi-stage chemical carcinogenesis induced by DMH is one of the most widely used models for intestinal cancer study . The disease is generally formed from cells that have undergone permanent and irreversible DNA damage detected by the micronucleus assay, for example. These mutations may remain dormant for long periods, including during the stage next to initiation, the promotion phase. In this phase, the cells are induced to proliferate and will result in precancerous lesions (Pitot and Dragan, 1991; Pitot, 1993) . Next, in the progression phase, the neoplasia is phenotypically expressed and can be histologically detected. Its characteristic is the genetic/genomic instability which, among other features, results in a high-proliferation rate, favoring the invasion of adjacent tissues and the metastasis. In this phase, biochemical changes are also observed that enable the clinical manifestation of the phenomenon, the last step of multi-stage carcinogenesis (Pitot, 1989) . The development of these changes in the intestinal mucosa is associated with inflammation.
DMH is classified as a pro-carcinogen agent, that is, it requires metabolic activation to become an active carcinogen (LaMont and O'Gorman, 1978) , and the activation mainly occurs in the liver, with oxidation of DMH in azomethane and, subsequently, in azoxymethane, which, in turn, is converted into methyl-azoxymethane (Weisburger, 1971; LaMont and O'Gorman, 1978) . At body temperature, methyl-azoxymethane is an unstable compound that undergoes decomposition spontaneously, giving rise to formaldehyde, water, nitrogen, and methyl diazonium, an alkylating agent that introduces a reactive carbonic ion capable of reacting with DNA, RNA, and proteins (Weisburger, 1971) . The DMH carcinogenic activity therefore involves DNA methylation into colonic epithelial cells (Hawks et al., 1974) . The methyl-azoxymethane also undergoes an enzyme-metabolizing process by the action of the alcohol dehydrogenase enzyme (present in the liver and colon, and at low concentrations in the jejunum and ileum), becoming methyl azoxy formaldehyde (Grab and Zedeck, 1977) .
In addition, the administration of DMH in rodents triggers a mild inflammatory reaction and an increased cell proliferation in the colonic mucosa. Its successive application results in continuous proliferation, with an increased number of cells in the DNA replication phase (Wargovich et al., 1983) , which triggers progressive hyperplasia of the crypt and hypertrophy of the mucosa (Richards, 1977) . DMH has then been shown to cause damage to the DNA synthesis, resulting in a pro-mutagenic lesion at the O 6 -methylguanine, which, as is known, induces GC → AT transitions. Such mutations are typically found in various colorectal cancer-related genes (Diehl et al., 2006) .
The aforementioned facts explain the occurrence of genotoxic damage (mean 23.43 ± 1.28 injured cells), mutagenic damage (mean 40.85 ± 1.90 micronucleated cells), and intestinal carcinogenesis markers (mean 14.85 ± 1.26 aberrant crypt foci). The administration of MPEE, a proven anti-inflammatory (Piornedo et al., 2011) , reduced all biomarkers in both short-term trials (comet and micronucleus assays) and the medium-term test (aberrant crypt foci). In the latter, the %DR reached 95.15, which presents the anticarcinogenic activity of M. polymorphum also in models of intestinal chemical carcinogenesis.
The chemopreventive (also called antimutagenic) compounds generally act by desmutagenesis and bioantimutagenesis (Waters et al., 1990) , and can directly act on the damage-inducing compound, mainly by chelating it or by inactivating it enzymatically, or even by working on the repairing enzymes, favoring the correction of the damage caused on the DNA by the carcinogenic agent (Kada et al., 1982; Kada and Shimoi, 1987) .
Thus, based on the results of the micronucleus assay, it is supposed that the MPEE can act by both desmutagenesis and bioantimutagenesis since the %DRs were high in all protocols; and the pre-treatment and post-treatment ones indicate desmutagenesis and bioantimutagenesis, respectively (Ishii et al., 2011; Pesarini et al., 2013) .
The reduction in circulating micronucleated cells can occur by splenic phagocytosis (Bazo et al., 2002; Ishii et al, 2011) , reason why this assay was also carried out in our study.
The administration of MPEE caused a discrete increase in the frequency of phagocytosis in the simultaneous and post-treatment protocols; when administered alone, the phagocytic activity is not increased. These data allow us to infer, therefore, that the main event related to the mutagenic damage reduction is chemoprevention, rather than the phagocytic process.
Considering the above, MPEE is not mutagenic, has chemopreventive potential it is able to reduce the incidence of aberrant cript foci. These data suggest that the extract has the potential for prospecting compounds for cancer prevention and treatment.
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